Clinical Trial Update: A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the enzyme Pancrelipase for safety and enzyme activity in patients with exocrine pancreatic insufficiency; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency
• Pancreatitis
• Steatorrhea

Drugs mentioned

• Pancrelipase (pancrelipase)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic | Phase 1 | Status: COMPLETED